The Correlation of D- Dimer and Neutrophil Lymphocyte Ratio (NLR) Levels on COVID-19 Mortality
Keywords:COVID-19, D-dimer, Neutrophil Lymphocyte Ratio, Mortality
Coronavirus disease 2019 (COVID-19) is a disease caused by a novel coronavirus or a new type of corona virus, namely severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). D-dimer and Neutrophil Lymphocyte Ratio are parameters that can be used as a predictor of mortality in COVID-19, so this study aims to determine the relationship between D-dimer levels and NLR with mortality in COVID-19 patients. The study used an analytic observational method with a cross sectional approach from medical record data at UNS Hospital. The population in this study were COVID-19 patients at UNS Hospital who had their D-dimer and NLR levels checked in the period November 2020-January 2021. The sample was taken using a simple random sampling technique. Bivariate data analysis with Spearman Rank Correlation Test. Obtained 72 samples. 46 male patients and 26 female patients with the highest age range of 40-59 years as many as 34 patients. Patients who experienced mortality as many as 24 people while the rest survived. Spearman's Rank test obtained p-values of D-dimer and neutrophil lymphocyte ratio (NLR) with mortality of COVID-19 patients 0.009 and <0.001, respectively. While the correlation coefficients for D-dimer and NLR on mortality were 0.308 and 0.515, respectively. There is a relationship between D-dimer and NLR levels with mortality in COVID-19 patients with a positive correlation.
Baloch, S., Baloch, M. A., Zheng, T., & Pei, X. (2020). The coronavirus disease 2019 (COVID-19) pandemic. The Tohoku Journal of Experimental Medicine, 250(4), 271–278. https://doi.org/10.1620/tjem.250.271
Bastug, A., Bodur, H., Erdogan, S., Gokcinar, D., Kazancioglu, S., Kosovali, B. D., Ozbay, B. O., Gok, G., Turan, I. O., & Yilmaz, G. (2020). Clinical and laboratory features of COVID-19: Predictors of severe prognosis. International Immunopharmacology, 88, 106950. https://doi.org/10.1016/j.intimp.2020.106950
Becker, R. C. (2020). COVID-19 update: Covid-19-associated coagulopathy. Journal of Thrombosis and Thrombolysis, 50(1), 54–67. https://doi.org/10.1007/s11239-020-02134-3
Breakey, N., & Escher, R. (2020). D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue? Swiss Medical Weekly, 150(2122), w20293–w20293. https://doi.org/10.4414/smw.2020.20293
Çalıca Utku, A., Budak, G., Karabay, O., Güçlü, E., Okan, H. D., & Vatan, A. (2020). Main symptoms in patients presenting in the COVID-19 period. Scottish Medical Journal, 65(4), 127–132. https://doi.org/10.1177/0036933020949253
Cevik, M., Kuppalli, K., Kindrachuk, J., & Peiris, M. (2020). Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ, 371. https://doi.org/10.1136/bmj.m3862
CDC. (2020). Coronavirus disease 2019 (COVID-19).CDC
Channappanavar, R., & Perlman, S. (2017). Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Seminars in Immunopathology, 39, 529–539. https://doi.org/10.1007/s00281-017-0629-x
Demelo-rodríguez, P., Cervilla-muñoz, E., Ordieres-ortega, L., & Parra-virto, A. (2020). Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels ☆. 192(May), 23–26. https://doi.org/10.1016/j.thromres.2020.05.018
Dhama, K., Khan, S., Tiwari, R., Sircar, S., Bhat, S., Malik, Y. S., Singh, K. P., Chaicumpa, W., Bonilla-Aldana, D. K., & Rodriguez-Morales, A. J. (2020). Coronavirus disease 2019–COVID-19. Clinical Microbiology Reviews, 33(4), e00028-20. https://doi.org/10.1128/cmr.00028-20
El-Anwar, M. W., Elzayat, S., & Fouad, Y. A. (2020). ENT manifestation in COVID-19 patients. Auris Nasus Larynx, 47(4), 559–564. https://doi.org/10.1016/j.anl.2020.06.003
Farasani, A. (2021). Biochemical role of serum ferratin and d-dimer parameters in COVID 19 diagnosis. Saudi Journal of Biological Sciences, 28(12), 7486–7490. https://doi.org/10.1016/j.sjbs.2021.08.040
Giannis, D., Ziogas, I. A., & Gianni, P. (2020). Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. Journal of Clinical Virology, 127, 104362. https://doi.org/10.1016/j.jcv.2020.104362
Gomez-Mesa, J. E., Galindo-Coral, S., Montes, M. C., & Martin, A. J. M. (2021). Thrombosis and Coagulopathy in COVID-19. Current Problems in Cardiology, 46(3), 100742. https://doi.org/10.1016/j.cpcardiol.2020.100742
Guo, J., Radloff, C. L., Wawrzynski, S. E., & Cloyes, K. G. (2020). Mining twitter to explore the emergence of COVID‐19 symptoms. Public Health Nursing, 37(6), 934–940. https://doi.org/10.1111/phn.12809
Harrison, A. G., Lin, T., & Wang, P. (2020). Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends in Immunology, 41(12), 1100–1115. https://doi.org/10.1016/j.it.2020.10.004
He, X., Yao, F., Chen, J., Wang, Y., Fang, X., Lin, X., Long, H., Wang, Q., & Wu, Q. (2021). The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients. Scientific Reports, 11(1), 1830. https://doi.org/10.1038/s41598-021-81300-w
Hornuss, D., Lange, B., Schroeter, N., Rieg, S., Kern, W. V, & Wagner, D. (2020). Anosmia in COVID-19 patients. Clinical Microbiology and Infection, 26(10), 1426–1427. https://doi.org/10.1016/j.cmi.2020.05.017
Hu, J., & Wang, Y. (2021). The clinical characteristics and risk factors of severe COVID-19. Gerontology, 67(3), 255–266. https://doi.org/10.1159/000513400
Iba, T., Levy, J. H., Levi, M., & Thachil, J. (2020). Coagulopathy in COVID‐19. Journal of Thrombosis and Haemostasis, 18(9), 2103–2109. https://doi.org/10.1111/jth.14975
Imran, M. M., Ahmad, U., Usman, U., Ali, M., Shaukat, A., & Gul, N. (2021). Retracted: Neutrophil/lymphocyte ratio—A marker of COVID‐19 pneumonia severity. International Journal of Clinical Practice, 75(4), e13698. https://doi.org/10.1111/ijcp.13698
Lamers, M. M., & Haagmans, B. L. (2022). SARS-CoV-2 pathogenesis. Nature Reviews Microbiology, 20(5), 270–284. https://doi.org/10.1038/s41579-022-00713-0
Lan, F.-Y., Filler, R., Mathew, S., Buley, J., Iliaki, E., Bruno-Murtha, L. A., Osgood, R., Christophi, C. A., Fernandez-Montero, A., & Kales, S. N. (2020). COVID-19 symptoms predictive of healthcare workers’ SARS-CoV-2 PCR results. PloS One, 15(6), e0235460. https://doi.org/10.1371/journal.pone.0235460
Li, Y., Zhao, K., Wei, H., Chen, W., Wang, W., Jia, L., Liu, Q., Zhang, J., Shan, T., & Peng, Z. (2020). Dynamic relationship between D‐dimer and COVID‐19 severity. British Journal of Haematology, 190(1), e24-e27. https://doi.org/10.1111/bjh.16811
Liu, Y.-C., Liao, C.-H., Chang, C.-F., Chou, C.-C., & Lin, Y.-R. (2020). A locally transmitted case of SARS-CoV-2 infection in Taiwan. New England Journal of Medicine, 382(11), 1070–1072. https://doi.org/10.1056/NEJMc2001573
Liu, Y., Du, X., Chen, J., Jin, Y., Peng, L., Wang, H. H. X., Luo, M., Chen, L., & Zhao, Y. (2020). Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. Journal of Infection, 81(1), e6–e12. https://doi.org/10.1016/j.jinf.2020.04.002
Mellett, L., & Khader, S. A. (2022). S100A8/A9 in COVID-19 pathogenesis: Impact on clinical outcomes. Cytokine & Growth Factor Reviews, 63, 90–97. https://doi.org/10.1016/j.cytogfr.2021.10.004
Menni, C., Valdes, A. M., Freidin, M. B., Ganesh, S., El-Sayed Moustafa, J. S., Visconti, A., Hysi, P., Bowyer, R. C. E., Mangino, M., & Falchi, M. (2020). Loss of smell and taste in combination with other symptoms is a strong predictor of COVID-19 infection. MedRxiv, 2004–2020. https://doi.org/10.1101/2020.04.05.20048421
Ozen, M., Yilmaz, A., Cakmak, V., Beyoglu, R., Oskay, A., Seyit, M., & Senol, H. (2021). D-Dimer as a potential biomarker for disease severity in COVID-19. The American Journal of Emergency Medicine, 40, 55–59. https://doi.org/10.1016/j.ajem.2020.12.023
Prather, K. A., Wang, C. C., & Schooley, R. T. (2020). Reducing transmission of SARS-CoV-2. Science, 368(6498), 1422–1424. https://doi.org/10.1126/science.abc6197
Sarohan, A. R., Kızıl, M., İnkaya, A. Ç., Mahmud, S., Akram, M., & Cen, O. (2021). A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder. Cellular Signalling, 87, 110121. https://doi.org/10.1016/j.cellsig.2021.110121
Simadibrata, D. M., Calvin, J., Wijaya, A. D., & Ibrahim, N. A. A. (2021). Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: A meta-analysis. The American Journal of Emergency Medicine, 42, 60–69. https://doi.org/10.1016/j.ajem.2021.01.006
Singh, K., Mittal, S., Gollapudi, S., Butzmann, A., Kumar, J., & Ohgami, R. S. (2021). A meta‐analysis of SARS‐CoV‐2 patients identifies the combinatorial significance of D‐dimer, C‐reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity. International Journal of Laboratory Hematology, 43(2), 324–328. https://doi.org/10.1111/ijlh.13354
Soni, M., Gopalakrishnan, R., Vaishya, R., & Prabu, P. (2020). D-dimer level is a useful predictor for mortality in patients with COVID-19: Analysis of 483 cases. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(6), 2245–2249. https://doi.org/10.1016/j.dsx.2020.11.007
Sun, S.-H., Chen, Q., Gu, H.-J., Yang, G., Wang, Y.-X., Huang, X.-Y., Liu, S.-S., Zhang, N.-N., Li, X.-F., & Xiong, R. (2020). A mouse model of SARS-CoV-2 infection and pathogenesis. Cell Host & Microbe, 28(1), 124–133. https://doi.org/10.1016/j.chom.2020.05.020
Tsai, P.-H., Lai, W.-Y., Lin, Y.-Y., Luo, Y.-H., Lin, Y.-T., Chen, H.-K., Chen, Y.-M., Lai, Y.-C., Kuo, L.-C., & Chen, S.-D. (2021). Clinical manifestation and disease progression in COVID-19 infection. Journal of the Chinese Medical Association, 84(1), 3–8. https://doi.org/10.1097/JCMA.0000000000000463
Vidali, S., Morosetti, D., Cossu, E., Luisi, M. L. E., Pancani, S., Semeraro, V., & Consales, G. (2020). D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review. ERJ Open Research, 6(2). https://doi.org/10.1183/23120541.00260-2020
Yu, H.-H., Qin, C., Chen, M., Wang, W., & Tian, D.-S. (2020). D-dimer level is associated with the severity of COVID-19. Thrombosis Research, 195, 219–225. https://doi.org/10.1016/j.thromres.2020.07.047
Yu, T., Cai, S., Zheng, Z., Cai, X., Liu, Y., Yin, S., Peng, J., & Xu, X. (2020). Association between clinical manifestations and prognosis in patients with COVID-19. Clinical Therapeutics, 42(6), 964–972. https://doi.org/10.1016/j.clinthera.2020.04.009
How to Cite
Copyright (c) 2023 JURNAL INFO KESEHATAN
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Ownership of copyright
The copyright in this website and the material on this website (including without limitation the text, computer code, artwork, photographs, images, music, audio material, video material and audio-visual material on this website) is owned by JURNAL INFO KESEHATAN and its licensors.
JURNAL INFO KESEHATAN grants to you a worldwide non-exclusive royalty-free revocable license to:
- view this website and the material on this website on a computer or mobile device via a web browser;
- copy and store this website and the material on this website in your web browser cache memory; and
- print pages from this website for your use.
- All articles published by JURNAL INFO KESEHATAN are licensed under the Creative Commons Attribution 4.0 International License. This permits anyone to copy, redistribute, remix, transmit and adapt the work provided the original work and source is appropriately cited.
JURNAL INFO KESEHATAN does not grant you any other rights in relation to this website or the material on this website. In other words, all other rights are reserved.
For the avoidance of doubt, you must not adapt, edit, change, transform, publish, republish, distribute, redistribute, broadcast, rebroadcast or show or play in public this website or the material on this website (in any form or media) without appropriately and conspicuously citing the original work and source or JURNAL INFO KESEHATAN prior written permission.
You may request permission to use the copyright materials on this website by writing to email@example.com.
Enforcement of copyright
JURNAL INFO KESEHATAN takes the protection of its copyright very seriously.
If JURNAL INFO KESEHATAN discovers that you have used its copyright materials in contravention of the license above, JURNAL INFO KESEHATAN may bring legal proceedings against you seeking monetary damages and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of JURNAL INFO KESEHATAN copyright materials that contravenes or may contravene the license above, please report this by email to firstname.lastname@example.org
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to email@example.com.